Renaissance Technologies - HUMACYTE INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$315
+53.7%
107,500
+50.1%
0.00%
Q2 2023$205
+39.5%
71,600
+50.1%
0.00%
Q1 2023$147
+194.0%
47,700
+100.4%
0.00%
Q4 2022$50
-100.0%
23,800
-88.6%
0.00%
-100.0%
Q3 2022$678,000
+1783.3%
208,000
+1773.9%
0.00%
Q2 2022$36,000
-89.2%
11,100
-76.4%
0.00%
Q1 2022$333,000
+211.2%
47,100
+218.2%
0.00%
Q4 2021$107,00014,8000.00%
Other shareholders
HUMACYTE INC shareholders Q4 2023
NameSharesValueWeighting ↓
York Capital Management Global Advisors, LLC 2,291,397$16,613,0003.70%
Monashee Investment Management LLC 399,910$2,899,0000.72%
Endowment Wealth Management, Inc. 96,618$700,0000.71%
Gladstone Institutional Advisory LLC 246,717$1,7890.14%
Diameter Capital Partners LP 300,338$2,177,0000.13%
CenterBook Partners LP 23,706$172,0000.10%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 900,100$6,526,000,0000.06%
Exos Asset Management LLC 16,139$117,0000.06%
Maven Securities LTD 200,000$1,450,0000.04%
VALLEY FORGE INVESTMENT CONSULTANTS INC ADV 11,000$80,0000.04%
View complete list of HUMACYTE INC shareholders